Additionally, older GLP-1 drugs, such as exenatide, have seen a decline in claims since the early 2010s as newer drugs were introduced
All that remains to be seen, and an absolute benefit of 1.5 per 100 people treated is certainly nothing to write home about
It allows you to bundle your treatments into a predictable monthly plan, making it easier to budget for consistent care and achieve your long-term aesthetic goals without the stress of large, one-time payments
Semaglutide works by acting on the brain, helping to control diabetes, supressing hunger, reducing food cravings, improving glycemic control, and changing the way your body digests food, boosting weight loss
The adverse events associated with GLP-1RA are predominantly GI, particularly nausea, vomiting, and diarrhea, and occur in 1050% of patients in clinical trials (Table 2) (32)